|Articles|March 8, 2017
Almac Diagnostics, EORTC Collaborate for Tumor Profiling
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.
Advertisement
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples from their clinical trial data and that of pan-European Cancer network, SPECTA.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Patient Input Comes in Too Late—and What Earlier Engagement Changes
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
What It Actually Means to Embed the Patient Voice in Trial Design
4
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
5